methylphenidate Hydrochloride
These highlights do not include all the information needed to use Methylphenidate HCl Extended-Release Tablets safely and effectively. See full prescribing information for Methylphenidate HCl Extended-Release Tablets. Methylphenidate HCl Extended-Release Tablets CII Initial U.S. Approval: 2000
dad446b7-b26c-44f2-9e30-4cbd10d8b23c
HUMAN PRESCRIPTION DRUG LABEL
Nov 29, 2023
Patriot Pharmaceuticals, LLC.
DUNS: 178220385
Products 4
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
methylphenidate hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (16)
methylphenidate hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (16)
methylphenidate hydrochloride
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (16)
methylphenidate hydrochloride
Product Details
FDA regulatory identification and product classification information